Home > News > 黄金城游戏
Industry Updates New Products Supplier News Upcoming Events business web

黄金城游戏

Hits:2178   Date: 7/4/2016
BioTek Instruments, Inc. affirms their ongoing investment across the North American microplate-based technology market with the expansion of their business in Canada. The dedicated 黄金城游戏 and support operation will focus on bringing enhanced applications and technical support throughout the country.
Dr. Charles Amirmansour, previously BioTek’s Applications and Business Development Manager, is now appointed as the Canadian Country Manager. “Canada’s Life Science sector continues to yield high-quality scientific research, supported by federal and provincial government focus and investments,” he states. “By expanding our footprint here, we can continue to provide first-in-class local, comprehensive and immediate 黄金城游戏, applications and service support to this rapidly growing market.”
BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate 黄金城游戏ation and software. These technologies are used to aid 黄金城游戏 research, facilitate drug discovery, provide rapid and cost-effective analysis, and enable sensitive, accurate quantification of molecules across diverse applications. BioTek espouses a “Think Possible” approach that sets the tone for fresh ideas, unsurpassed customer service and original innovations. As such, they are often honored for local accomplishments and technological innovations, including Best Places to Work in Vermont, North American New Product Innovation Award for Workflow Solutions in Life Sciences, and Scientists' Choice Awards®: Drug Discovery Product of the Year and Best New Life Sciences Product.